Home>Topics>Companies>AstraZeneca

AstraZeneca

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. New Cancer Drugs: First Movers Will Win

    Video Reports

    Fri, 27 Mar 2015

    space. They are followed closely by Merck (MRK). And we think, longer term, both Roche (ROG) and [TICKER:AZN] AstraZeneca (AZN) are also well positioned. On the biotech side, we thing Insight has some attractive early-stage assets

    Astrazeneca found at 1:37

    by Merck (MRK). And we think, longer term, both Roche (ROG) and [TICKER:AZN] AstraZeneca (AZN) are also well positioned. On the biotech side, we thing Insight has some attractive early-stage assets. Of the companies I just
  2. BRIEF- AstraZeneca to collaborate with Harvard Stem Cell Institute in diabetes

    Headlines

    Wed, 25 Mar 2015

    * To collaborate with Harvard Stem Cell Institute in diabetesFurther company coverage: (Reporting By Ben Hirschler)

  3. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Headlines

    Mon, 23 Mar 2015

    management is willing to back away when necessary, as evidenced by the recent decision to sell a large portion of its Western European generics operations in addition to the recent divestment of respiratory products to AstraZeneca AZN.

  4. BRIEF- AstraZeneca announces collaboration with Japan's Daiichi Sankyo

    Headlines

    Thu, 19 Mar 2015

    * Under terms of agreement, Daiichi Sankyo Inc will pay a $200 mln up-front fee and subsequent sales-related payments of up to $625 mln

  5. AstraZeneca two-in-one drug succeeds in lung disease test

    Headlines

    Wed, 18 Mar 2015

    LONDON, March 18 (Reuters) - AstraZeneca said on Wednesday its experimental lung drug PT003 for chronic lung disease had proved successful in two final-stage Phase III trials, boosting hopes for the...

  6. BRIEF- AstraZeneca reports positive Phase III results for PT003 in COPD

    Headlines

    Wed, 18 Mar 2015

    * PT003 is first LAMA/LABA combination to be delivered in a pressurised metered dose inhaler

  7. Long-term use of AstraZeneca heart drug brings benefits, some risks

    Headlines

    Sat, 14 Mar 2015

    LONDON, March 14 (Reuters) - Long-term use of AstraZeneca 's drug Brilinta can cut the risk of death, another heart attack or stroke in patients with a history of past attacks by 16 percent, a keenly awaited clinical trial showed on Saturday.

  8. TSB leads rise in UK stocks as Sabadell makes takeover bid

    Headlines

    Thu, 12 Mar 2015

    LONDON, March 12 (Reuters) - UK shares rose on Thursday, led by domestic bank TSB after it received a takeover offer, and by drugs group AstraZeneca on optimism about key trial results.

  9. TSB leads rise in UK stocks as Sabadell makes takeover bid

    Headlines

    Thu, 12 Mar 2015

    LONDON, March 12 (Reuters) - UK shares rose on Thursday, led by domestic bank TSB after it received a takeover offer, and by drugs group AstraZeneca on optimism about key trial results.

  10. AstraZeneca keeps 2015 outlook after financial reporting change

    Headlines

    Fri, 6 Mar 2015

    LONDON, March 6 (Reuters) - Drugmaker AstraZeneca said on Friday it would change the way it reported results with effect from the first quarter of 2015 to make revenue from so-called externalisation deals more visible to investors.

« Prev12345Next »
Content Partners